Nps Pharmaceuticals Inc Watch

from SC TO-C 81 pages Agreement and Plan of Merger Dated as of January 11, 2015 Among Nps Pharmaceuticals, Inc., Shire Pharmaceutical Holdings Ireland Limited, Knight Newco 2, Inc. and Shire PLC

from SC TO-C 81 pages Agreement and Plan of Merger Dated as of January 11, 2015 Among Nps Pharmaceuticals, Inc., Shire Pharmaceutical Holdings Ireland Limited, Knight Newco 2, Inc. and Shire PLC

from 8-K 81 pages Agreement and Plan of Merger Dated as of January 11, 2015 Among Nps Pharmaceuticals, Inc., Shire Pharmaceutical Holdings Ireland Limited, Knight Newco 2, Inc. and Shire PLC

from 8-K 41 pages Termination and Transition Agreement Dated as of March 18, 2013 by and Among Nps Pharmaceuticals, Inc., Takeda Gmbh, and Takeda Pharma a/S Termination and Transition Agreement

from SC 13G 1 page Statement of Control Person

from SC 13G 1 page Statement of Control Person

from S-3 ~20 pages Registration Rights Agreement

from S-3 ~10 pages Restricted Stock Purchase Agreement

from S-3 ~10 pages Mutual Termination and Release Agreement

from 8-K 79 pages Agreement and Plan of Reorganization by and Among Nps Pharmaceuticals, Inc. Enzon Pharmaceuticals, Inc. Momentum Merger Corporation Newton Acquisition Corporation and Einstein Acquisition Corporation Dated as of February 19, 2003

from 8-K >50 pages Arrangement Agreement, Dated Sep. 27, 1999

from SC 13G/A 1 page <page> Page 10 of 11 Exhibit B Joint Filing Agreement Pursuant to Rule 13d-1(f) (1) This Agreement Is Made Pursuant to Rule 13d-1(f)(1) Under the Securities Exchange Act of 1934, as Amended (The "Act") by and Among the Parties Listed Below, Each Referred to Herein as a "Joint Filer." the Joint Filers Agree That a Statement of Beneficial Ownership as Required by Section 13(d) of the Act and the Rules Thereunder May Be Filed on Each of Their Behalf on Schedule 13d or Schedule 13g, as Appropriate, and That Said Joint Filing May Thereafter Be Amended by Further Joint Filings. the Joint Filers States That They Each Satisfy the Requirements for Making a Joint Filing Under Rule 13d-1. Dated: February 2, 1998 /S/ Jeffrey S. Lambert - Mark E. Strome Strome Susskind Investment Management, L.P. by Ssco, Inc., Its General Partner By: /S/ Jeffrey S. Lambert Jeffrey S. Lambert, Chief Financial Officer Ssco, Inc. By: /S/ Jeffrey S. Lambert Jeffrey S. Lambert, Chief Financial Officer